Johnson & Johnson secures 400 million doses for Africa: Janssen vaccine to African Union

Pharmaceutical company Johnson & Johnson has announced that it will supply the Covid Janssen vaccine to enable a major step forward in the African Union’s strategy to vaccinate 780 million people.

Africa, 400 million Janssen doses on the way: Johnson & Johnson announcement

The pharmaceutical company Johnson & Johnson has announced that it will supply the African Union with 400 million doses of its Covid vaccine, a serum that requires only one administration – as opposed to two for other vaccines – thus speeding up procedures in different member states and cutting costs on vaccine procurement.

However, the first 220 million doses will not arrive until late 2021, with the remainder to be delivered in 2022.

According to the international press, the Johnson & Johnson doses will allow the African Union to take a decisive step forward in its strategy to immunise 60% of the population, i.e. 780 million Africans.

Read Also:

Covid In Africa, From Senegal “A Gesture Of African Solidarity” For The Gambia And Guinea Bissau: 20,000 Doses Donated

Africa, Tedros Ghebreyesus (WHO Director): ‘Kenya And Rwanda As Models Against Covid’

Africa, Lack Of Vaccines: ‘Risk Of Increasing Covid Variants’

COVID-19 Vaccine, Johnson & Johnson Seeks Authorisation From Ema For Single Dose

Russia Registers Sputnik Light, Single-Dose Vaccine Formula

South Africa, Astrazeneca ‘Ineffective’ Against South African Variant: Government Blocks Vaccination



Agenzia Dire

You might also like